Stockscreener 앱 받기
4.67
5.18%
0.23
전일 마감가:
$4.44
열려 있는:
$4.52
하루 거래량:
145.33K
Relative Volume:
0.24
시가총액:
$155.03M
수익:
-
순이익/손실:
$-86.60M
주가수익비율:
-1.6488
EPS:
-2.8324
순현금흐름:
$-67.37M
1주 성능:
-1.27%
1개월 성능:
+4.47%
6개월 성능:
+18.23%
1년 성능:
-61.02%
1일 변동 폭
$4.39
$4.67
1주일 범위
$4.3418
$4.81
52주 변동 폭
$1.45
$12.76
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
명칭
Lexeo Therapeutics Inc
전화
(212) 547-9879
주소
345 PARK AVENUE SOUTH, NEW YORK
LXEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
4.67 | 239.68M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-31 | 개시 | Oppenheimer | Outperform |
| 2024-06-13 | 개시 | Robert W. Baird | Outperform |
| 2024-06-06 | 개시 | H.C. Wainwright | Buy |
| 2023-11-28 | 개시 | Chardan Capital Markets | Buy |
| 2023-11-28 | 개시 | JP Morgan | Overweight |
| 2023-11-28 | 개시 | Leerink Partners | Outperform |
| 2023-11-28 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-28 | 개시 | Stifel | Buy |
모두보기
Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스
What makes Lexeo Therapeutics Inc. stock price move sharplyLow Float Short Squeeze Picks - thegnnews.com
Lexeo Therapeutics Inc. Matches Institutional Buying FilterBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN
Lexeo Therapeutics Inc. Stock Approaches Key Moving AverageChart Breakout Buy Signal Detection Confirmed - beatles.ru
Traders Watching For Reversal Pattern in Lexeo Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
Oppenheimer Begins Coverage on Lexeo Therapeutics (NASDAQ:LXEO) - MarketBeat
How does Lexeo Therapeutics Inc. generate profit in a changing economyBuild wealth with reliable stock picks - Jammu Links News
How strong is Lexeo Therapeutics Inc. company’s balance sheetGet real-time updates on market trends - Jammu Links News
What is Lexeo Therapeutics Inc. company’s growth strategyFree Risk Assessment Services - Jammu Links News
Is it the right time to buy Lexeo Therapeutics Inc. stockAchieve consistent profits with expert advice - Jammu Links News
How many analysts rate Lexeo Therapeutics Inc. as a “Buy”Superior returns - Jammu Links News
Published on: 2025-08-04 05:32:29 - Jammu Links News
What are the technical indicators suggesting about Lexeo Therapeutics Inc.Consistent double returns - Jammu Links News
What are Lexeo Therapeutics Inc. company’s key revenue driversPhenomenal returns - Jammu Links News
How does Lexeo Therapeutics Inc. compare to its industry peersMaximize your gains with professional insights - Jammu Links News
What is the risk reward ratio of investing in Lexeo Therapeutics Inc. stockMaximize gains with professional stock picks - Jammu Links News
Is Lexeo Therapeutics Inc. a good long term investmentMarket-beating performance - Jammu Links News
What are analysts’ price targets for Lexeo Therapeutics Inc. in the next 12 monthsBuild a portfolio with strong long-term growth - Jammu Links News
Published on: 2025-08-03 06:15:28 - Jammu Links News
What is the dividend policy of Lexeo Therapeutics Inc. stockDynamic profit opportunities - Jammu Links News
How volatile is Lexeo Therapeutics Inc. stock compared to the marketDiscover market opportunities with real-time data - Jammu Links News
Lexeo Therapeutics Analyst Begins Coverage on Bullish Note; Top 3 Initiations for Thursday - AInvest
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga
Oppenheimer Initiates Lexeo Therapeutics(LXEO.US) With Buy Rating, Announces Target Price $20 - 富途牛牛
Lexeo Therapeutics Initiates Coverage: Oppenheimer Outperform Rating with $20 PT - AInvest
Lexeo Therapeutics shares rise 7.31% premarket after FDA grants breakthrough therapy designation to LX2006. - AInvest
Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating By Investing.com - Investing.com India
Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating - Investing.com Australia
Should I hold or sell Lexeo Therapeutics Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News
Stifel Reiterates Buy Rating for Lexeo Therapeutics with $21 Price Target Following FDA Breakthrough Therapy Designation for LX2006 - AInvest
Candlestick Reversal Detected on Lexeo Therapeutics Inc.’s ChartPotential Breakout Stock List Published This Week - metal.it
Lexeo Therapeutics' LX2006 Receives Breakthrough Therapy Designation from FDA, Shares Rise 17% - AInvest
Lexeo Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowGrowth Based Stock Signal Screener Updated - metal.it
11 Best New Penny Stocks to Buy Right Now - Insider Monkey
How did LXEO's operating expenses trend in Q4 2024? - AInvest
Does Lexeo Therapeutics Inc. stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
Will Lexeo Therapeutics Inc. stock split in the near futureFree Smart Money Stock Analysis - metal.it
When is Lexeo Therapeutics Inc. stock expected to show significant growthProven strategies for superior portfolio growth - jammulinksnews.com
Why is Lexeo Therapeutics Inc. stock attracting strong analyst attentionRapid-fire capital growth - Jammu Links News
Lexeo Therapeutics Inc (LXEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
3.06%
자본화:
|
볼륨(24시간):